Progranulin modulates cartilage-specific gene expression via sirtuin 1–mediated deacetylation of the transcription factors SOX9 and P65

• Published in: The Journal of biological chemistry Vol. 295; no. 39; pp. 13640 - 13650
• Main Authors: Feng, Dongxu, Kang, Xiaomin, Wang, Ruiqi, Chen, He, Zhang, Kun, Feng, Weilou, Li, Huixia, Zhu, Yangjun, Wu, Shufang
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 25.09.2020; American Society for Biochemistry and Molecular Biology
• Subjects: Acetylation; Aged; Animals; cartilage; Cartilage, Articular - metabolism; Cell Biology; Cells, Cultured; chondrocytes; Chondrocytes - metabolism; deacetylation; growth factor; Humans; inflammation; joint disease; Neoplasm Proteins - metabolism; Nucleocytoplasmic Transport Proteins - metabolism; osteoarthritis; PGRN; progranulin; Progranulins - metabolism; Rats; Rats, Sprague-Dawley; Recombinant Proteins - metabolism; SIRT1; sirtuin 1; Sirtuin 1 - deficiency; Sirtuin 1 - genetics; Sirtuin 1 - metabolism; SOX9 Transcription Factor - metabolism; sirtuin 1; growth factor; chondrocytes; inflammation; osteoarthritis; PGRN; deacetylation; cartilage; progranulin; SIRT1; joint disease
• ISSN: 0021-9258; 1083-351X
• DOI: 10.1074/jbc.RA119.011164

Progranulin (PGRN) is an autocrine growth factor that exerts crucial roles within cartilage tissue; however, the molecular mechanisms underlying PGRN-mediated cartilage homeostasis remain elusive. In the present study, we investigated the role of PGRN in regulating chondrocyte homeostasis and its therapeutic potential for managing osteoarthritis (OA). We found that PGRN levels are significantly increased in human cartilage in mild OA and that its expression is decreased in the cartilage in severe OA. In vitro, treatment of primary rat chondrocytes with recombinant PGRN significantly enhanced the levels of collagen type II α 1 chain (COL2A1) and aggrecan, and attenuated TNFα-induced up-regulation of matrix metallopeptidase 13 (MMP13) and ADAM metallopeptidase with thrombospondin type 1 motif 5 (ADAMTS5) in chondrocytes. These effects were abrogated in SIRT1−/− cells, indicating a causative role of SIRT1 in the effects of PGRN on protein expression in chondrocytes. Mechanistically, PGRN increased SIRT1 expression and activity, which reduced the acetylation levels of SRY-box transcription factor (SOX9) and transcription factor P65 (P65) and thereby promoted nuclear translocation of SOX9 and inhibited TNFα-induced P65 nuclear accumulation to maintain chondrocyte homeostasis. In conclusion, our findings reveal a mechanism of action for PGRN that maintains cartilage homeostasis and supports the notion that PGRN up-regulation may be a promising strategy for managing OA.